Trials / Conditions / Stage IV Uterine Corpus Cancer

Stage IV Uterine Corpus Cancer

12 registered clinical trials studyying Stage IV Uterine Corpus Cancer.

Status	Trial	Sponsor	Phase
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Completed	Prognostic Biomarkers in Patients With Endometrial Cancer NCT01208467	Gynecologic Oncology Group	—
Completed	Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa NCT01098630	Gynecologic Oncology Group	—
Completed	Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer NCT01344837	Gynecologic Oncology Group	—
Completed	Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer NCT01198171	Gynecologic Oncology Group	—
Completed	Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer NCT01164735	Gynecologic Oncology Group	—
Withdrawn	Biomarkers in Samples From Patients With Endometrial Cancer NCT01199250	Gynecologic Oncology Group	—
Terminated	Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extr NCT00577317	Gynecologic Oncology Group	Phase 3
Completed	Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus NCT00064025	Gynecologic Oncology Group	Phase 2
Completed	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Ca NCT00005840	Gynecologic Oncology Group	Phase 1
Completed	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Ca NCT00005830	Gynecologic Oncology Group	Phase 1
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—